Erythropoietin
- Generic Name
- Erythropoietin
- Brand Names
- Procrit, Eprex, Epprex, Epoetin Alfa Hexal, Silapo, Biopoin, Abseamed, Eporatio, NeoRecormon, Epogen, Retacrit
- Drug Type
- Biotech
- Chemical Formula
- -
- CAS Number
- 11096-26-7
- Unique Ingredient Identifier
- 64FS3BFH5W
- Background
Erythropoietin (EPO) is a growth factor produced in the kidneys that stimulates the production of red blood cells. It works by promoting the division and differentiation of committed erythroid progenitors in the bone marrow . Epoetin alfa (Epoge) was developed by Amgen Inc. in 1983 as the first rhEPO commercialized in the United States, followed by other alf...
- Indication
用于肾功能不全合并的贫血，艾滋病本身或因治疗引起的贫血，恶性肿瘤伴发的贫血及风湿性贫血等。另外，为择期手术储存自体血而反复采血的患者，同时应用本品可预防发生贫血。
- Associated Conditions
- Anemia, Blood Loss During Surgery, Anemia caused by Zidovudine
- Associated Therapies
- -
Erythropoietin to Improve Critical Care Patient Outcomes
- Conditions
- Interventions
- First Posted Date
- 2021-10-15
- Last Posted Date
- 2022-10-10
- Lead Sponsor
- University Hospital, Angers
- Target Recruit Count
- 42
- Registration Number
- NCT05080049
- Locations
- 🇫🇷
Cholet Hospital, Cholet, France
🇫🇷UH Tours, Tours, France
A Study to Investigate the Effect of Roxadustat Versus Recombinant Human Erythropoietin (rHuEPO) on Oral Iron Absorption in Chinese Patients With Anemia of Chronic Kidney Disease (CKD)
- First Posted Date
- 2020-12-04
- Last Posted Date
- 2024-04-22
- Lead Sponsor
- AstraZeneca
- Target Recruit Count
- 25
- Registration Number
- NCT04655027
- Locations
- 🇨🇳
Research Site, Wuhan, China
Prognostic Value of Serum Erythropoietin Level,Ferritin Level and Fibrinogen in Adult Low Risk MDS
- Conditions
- First Posted Date
- 2020-10-05
- Last Posted Date
- 2020-10-05
- Lead Sponsor
- Assiut University
- Target Recruit Count
- 50
- Registration Number
- NCT04573686
Roxadustat for Anemia in Patients With CKD
- Conditions
- Interventions
- First Posted Date
- 2020-08-06
- Last Posted Date
- 2021-01-22
- Lead Sponsor
- Shenzhen Second People's Hospital
- Target Recruit Count
- 200
- Registration Number
- NCT04502537
- Locations
- 🇨🇳
Shenzhen Second People's Hospital, Shenzhen, China
Subcutaneous Injection of Erythropoietin on Visual Functions in Patients With Late Onset Optic Neuropathy
- First Posted Date
- 2020-07-14
- Last Posted Date
- 2021-04-01
- Lead Sponsor
- Alexandria University
- Target Recruit Count
- 20
- Registration Number
- NCT04469777
- Locations
- 🇪🇬
Alexandria Faculty of Medicine, Alexandria, Egypt
Erythropoietin And/Or Iron Sucrose For Perioperative Anemia Management In Hip and Knee Arthroplasty
- Conditions
- Interventions
- First Posted Date
- 2019-04-17
- Last Posted Date
- 2019-04-25
- Lead Sponsor
- Peking Union Medical College Hospital
- Target Recruit Count
- 780
- Registration Number
- NCT03917394
- Locations
- 🇨🇳
Peking Union Medical College Hospital, Beijing, Beijing, China
Effect of Erythropoietin on Neurodevelopmental Outcomes in Very Preterm Infants With Intraventricular Hemorrhage
- First Posted Date
- 2019-04-16
- Last Posted Date
- 2021-02-26
- Lead Sponsor
- Zhengzhou University
- Target Recruit Count
- 316
- Registration Number
- NCT03914690
- Locations
- 🇨🇳
Third Affiliated Hospital of Zhengzhou University, Zhengzhou, Henan, China
Effect of Recombinant Human EPO on the Postoperative Neurologic Outcome in Pediatric Moyamoya Patients
- Conditions
- Interventions
- First Posted Date
- 2019-03-20
- Last Posted Date
- 2023-11-22
- Lead Sponsor
- Seoul National University Hospital
- Target Recruit Count
- 60
- Registration Number
- NCT03882060
- Locations
- 🇰🇷
Seoul National University Hospital, Seoul, Korea, Republic of
Use of Erythropoietin to Expand Regulatory T Cells in Autoimmune Liver Disease
- First Posted Date
- 2019-02-15
- Last Posted Date
- 2021-03-04
- Lead Sponsor
- Northwestern University
- Target Recruit Count
- 6
- Registration Number
- NCT03842254
- Locations
- 🇺🇸
Northwestern Medicine, Chicago, Illinois, United States
🇺🇸Mount Sinai, New York, New York, United States
Erythropoietin in Hemolytic Uremic Syndrome
- First Posted Date
- 2018-12-17
- Last Posted Date
- 2021-01-13
- Lead Sponsor
- Hospital General de Niños Pedro de Elizalde
- Target Recruit Count
- 24
- Registration Number
- NCT03776851
- Locations
- 🇦🇷
HGNPE, Caba, Argentina
Drug Development Updates
Stay informed with timely notifications on clinical trials, regulatory changes, and research advancements related to this medication.